CMLCX
Price
$59.62
Change
+$0.38 (+0.64%)
Updated
Jul 3 closing price
Net Assets
109.01B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

CMLCX vs VIVAX

Header iconCMLCX vs VIVAX Comparison
Open Charts CMLCX vs VIVAXBanner chart's image
American Funds American Mutual 529C
Price$59.62
Change+$0.38 (+0.64%)
VolumeN/A
Net Assets109.01B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
CMLCX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CMLCX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMLCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. CMLCX (109B). VIVAX pays higher dividends than CMLCX: VIVAX (2.06) vs CMLCX (0.83). CMLCX was incepted earlier than VIVAX: CMLCX (23 years) vs VIVAX (33 years). CMLCX (1.36) is less costly to investors than VIVAX (0.17). CMLCX is a more actively managed with annual turnover of: 31.00 vs. VIVAX (9.00). CMLCX has a lower initial minimum investment than VIVAX: CMLCX (250) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. CMLCX (10.95). VIVAX return over 5 years is better than : 80.14 vs. CMLCX (58.15).
CMLCXVIVAXCMLCX / VIVAX
Total Expense Ratio1.360.17800%
Annual Report Gross Expense Ratio1.360.17800%
Fund Existence23 years33 years-
Gain YTD9.3326.209150%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets109B189B58%
Annual Yield % from dividends0.832.0640%
Returns for 1 year10.9512.0491%
Returns for 3 years27.4635.1678%
Returns for 5 years58.1580.1473%
Returns for 10 years84.98115.7473%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.